Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease

Parkinson Disease Clinical Trial

Official title: Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease

Status Terminated

Clinical Trial Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within Parkinson's patients. vCR will be administered with a device called the VT Brain Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. This study will include a dedicated sham that will aid in understanding true treatment effects from vCR.

Clinical Trial Description

Current treatments for Parkinson's disease include medications, surgical measures, or a combination of both. However, long term use of medications can result intolerable side effects, especially at higher doses. If patients under go Deep Brain Stimulation (DBS) surgery, risks include risk of stroke, infection, seizure, hemorrhage or others we may not anticipate. Our investigators hope to confirm a non-invasive method of applying the stimulation by vibrotactile stimulation delivered through the fingertips will alleviate severity in motor symptoms in Parkinson's patients ;

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT04877015
• Study type: Interventional
• Source: Synergic Medical Technologies, Inc.
• Status: Terminated
• Phase: N/A
• Start date: December 7, 2021
• Completion date: October 14, 2022